These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2278894)

  • 1. The Crookshank lecture: biological response modifiers in the treatment of cancer.
    Guillou PJ
    Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):347-53. PubMed ID: 2278894
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy with sensitized lymphocytes.
    Chang AE; Shu S
    Cancer Invest; 1992; 10(5):357-69. PubMed ID: 1393687
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with interleukin-2 and tumor-derived activated lymphocytes.
    Oldham RK
    Immunol Ser; 1994; 61():251-71. PubMed ID: 8011748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology].
    Barón Saura JM; Pizarro Redondo A; Berrocal Jaime A; González Barón M
    Rev Clin Esp; 1991 May; 188(9):468-72. PubMed ID: 1896596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive cellular immunotherapy of cancer.
    Winter H; Fox BA
    Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-derived activated cells: culture conditions and characterization.
    Maleckar JR; Friddell CS; Lewko WM; Yannelli JR; West WH; Oldham RK
    Immunol Ser; 1989; 48():159-73. PubMed ID: 2488319
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of interleukin-2.
    von Rohr A; Thatcher N
    Prog Growth Factor Res; 1992; 4(3):229-46. PubMed ID: 1307490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer.
    Yannelli JR
    J Immunol Methods; 1991 May; 139(1):1-16. PubMed ID: 2040807
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural killer cells: immunobiology and clinical prospects.
    Lotzová E
    Cancer Invest; 1991; 9(2):173-84. PubMed ID: 1863873
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 11. New perspectives in immunotherapy of leukemia.
    Lotzová E
    Immunol Ser; 1994; 61():231-8. PubMed ID: 8011747
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells.
    Yarbro JW
    Semin Surg Oncol; 1991; 7(4):183-91. PubMed ID: 1925249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy.
    Sznol M; Urba WJ
    Cancer Chemother Biol Response Modif; 1994; 15():213-25. PubMed ID: 7779587
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive immunotherapy of urologic tumors.
    Belldegrun A; Rosenberg SA
    Cancer Treat Res; 1989; 46():213-33. PubMed ID: 2577191
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of T lymphocytes in the immunotherapy of tumours.
    Brondz BD; Balashov KE
    Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive cellular therapy.
    Sznol M; Urba WJ
    Cancer Chemother Biol Response Modif; 1992; 13():191-204. PubMed ID: 1389910
    [No Abstract]   [Full Text] [Related]  

  • 17. Adoptive cellular immunotherapy of cancer: future perspectives.
    Stevenson HC
    Immunol Ser; 1989; 48():229-36. PubMed ID: 2488324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 19. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.
    Kim S; Haas GP; Hillman GG
    Cytokines Mol Ther; 1996 Mar; 2(1):13-9. PubMed ID: 9384685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.